These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. New antiepileptic drugs: a systematic review of their efficacy and tolerability. Marson AG; Kadir ZA; Chadwick DW BMJ; 1996 Nov; 313(7066):1169-74. PubMed ID: 8916746 [TBL] [Abstract][Full Text] [Related]
64. Therapeutic safety monitoring: what to look for and when to look for it. Harden CL Epilepsia; 2000; 41 Suppl 8():S37-44. PubMed ID: 11092611 [TBL] [Abstract][Full Text] [Related]
65. A new look at the second-generation antiepileptic drugs: a decade of experience. LaRoche SM Neurologist; 2007 May; 13(3):133-9. PubMed ID: 17495757 [TBL] [Abstract][Full Text] [Related]
66. Practical insights and clinical experience with combinations of the new antiepileptic drugs. Montouris GD Neurology; 1995 Mar; 45(3 Suppl 2):S25-8. PubMed ID: 7898742 [TBL] [Abstract][Full Text] [Related]
67. Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom. Wong IC; Mawer GE; Sander JW Epilepsia; 2001 Feb; 42(2):237-44. PubMed ID: 11240596 [TBL] [Abstract][Full Text] [Related]
68. Pharmacotherapeutic issues for women of childbearing age with epilepsy. Chang SI; McAuley JW Ann Pharmacother; 1998; 32(7-8):794-801. PubMed ID: 9681096 [TBL] [Abstract][Full Text] [Related]
69. The new generation of antiepileptic drugs: advantages and disadvantages. Perucca E Br J Clin Pharmacol; 1996 Nov; 42(5):531-43. PubMed ID: 8951184 [TBL] [Abstract][Full Text] [Related]
70. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F; Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013 [TBL] [Abstract][Full Text] [Related]
71. Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability. Simister RJ; Sander JW; Koepp MJ Epilepsy Behav; 2007 Mar; 10(2):336-9. PubMed ID: 17267290 [TBL] [Abstract][Full Text] [Related]
72. Clinical administration of new antiepileptic drugs: an overview of safety and efficacy. Chadwick DW; Marson T; Kadir Z Epilepsia; 1996; 37 Suppl 6():S17-22. PubMed ID: 8941038 [TBL] [Abstract][Full Text] [Related]
73. Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy. Moavero R; Santarone ME; Galasso C; Curatolo P Brain Dev; 2017 Jun; 39(6):464-469. PubMed ID: 28202262 [TBL] [Abstract][Full Text] [Related]
74. [Anticonvulsive drug therapy. Historical and current aspects]. Bauer J; Elger CE Nervenarzt; 1995 Jun; 66(6):403-11. PubMed ID: 7543658 [TBL] [Abstract][Full Text] [Related]
75. New antiepileptic drugs in pediatric epilepsy. Hwang H; Kim KJ Brain Dev; 2008 Oct; 30(9):549-55. PubMed ID: 18328657 [TBL] [Abstract][Full Text] [Related]
76. The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy. Wong IC; Chadwick DW; Fenwick PB; Mawer GE; Sander JW Epilepsia; 1999 Oct; 40(10):1439-45. PubMed ID: 10528941 [TBL] [Abstract][Full Text] [Related]
77. New drugs for persons with epilepsy. Blum DE Adv Neurol; 1998; 76():57-87. PubMed ID: 9408464 [TBL] [Abstract][Full Text] [Related]
78. The epidemiology of drug resistant epilepsy and adverse effects of antiepileptic drugs. Chadwick D Acta Neurochir Suppl (Wien); 1990; 50():32-7. PubMed ID: 2129090 [TBL] [Abstract][Full Text] [Related]
79. Efficacy, pharmacology, and adverse effects of antiepileptic drugs. Holland KD Neurol Clin; 2001 May; 19(2):313-45. PubMed ID: 11358747 [TBL] [Abstract][Full Text] [Related]